Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells

Experimental Hematology

Volumn 27, Issue 2, 1999, Pages 259-265

  Bai, Amuguleng ^a   Kojima, Hiroshi ^a   Hori, Mitsuo ^a   Nara, Nobuo ^b   Komeno, Takuya ^a   Hasegawa, Yuichi ^a   Ninomiya, Haruhiko ^a   Abe, Tsukasa ^a   Nagasawa, Toshiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

AML; Apoptosis; Ara C; Chemotherapy; G CSF

Indexed keywords

ACLARUBICIN; ANTINEOPLASTIC AGENT; CYTARABINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADULT; AGED; ANEMIA; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CYTARABINE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED;

ARA;

EID: 0033000219     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00041-1     Document Type: Article

References (20)

1. Miyauchi J., Kelleher C.A., Wang C., Minkin S., McCulloch E.A. Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. Blood. 73:1989;1272.
2. Lista P., Brizzi M.F., Rossi M., Resegotti L., Clark S.C., Pegoraro L. Different sensitivity of normal and leukemic progenitor cells to Ara-C and IL-3 combined treatment. Br J Haematol. 76:1990;21.
3. te Boekhorst P.A.W., Lowenberg B., Vlastuin M., Sonneveld P. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. Leukemia. 7:1993;1191.
4. Tafuri A., Andreeff M. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia. 4:1990;826.
5. Yamada K., Furusawa S., Saito K., Waga K., Koike T., Arimura H., Aoyagi A., Yamato H., Sakuma H., Tsunogake S., Yoshida M., Aoyagi M., Nakamura Y., Enokihara H., Tanaka K., Nakazawa K., Shishido H. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia. a pilot study Leukemia. 9:1995;10.
6. Gunji H., Kharbanda S., Kufe D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D arabinofuranosylcytosine. Cancer Res. 51:1991;741.
7. Kaufmann S.H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs. a cautionary note Cancer Res. 49:1989;5870.
8. Bhalla K., Ibrado A.M., Tourkina E., Tang C., Grant S., Bullock G., Huang Y., Ponnathpur V., Mahoney M.E. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood. 82:1993;3133.
9. Mayer P., Carpentier Y., Gorisse M.C., Desoize B. Culture conditions modulates the effects of aclacinomycin A on growth, differentiation, and apoptosis of HL60 cells. Anticancer Res. 14:1994;2331.
10. Bhalla K., Tang C., Ibrado A.M., Grant S., Tourkina E., Holladay C., Hughes M., Mahoney M.E., Huang Y. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human leukemia cells. Blood. 80:1992;2883.
11. Gorczyca W., Bigman K., Mittelman A., Ahmed T., Gong J., Melamed M.R., Darzynkiewicz Z. Induction of DNA strand breaks associated with apoptosis during treatment of leukemia. Leukemia. 7:1993;659.
12. Li X., Gong J., Feldman E., Seiter K., Traganos F., Darzynkiewicz Z. Apoptotic cell death during treatment of leukemias. Leuk Lymphoma. 13:1994;65.
13. Tsangaris G.T.H., Moschovi M., Mikraki V., Vrachnou E., Tzortzatou-Stathopoulou F. Study of apoptosis in peripheral blood of patients with acute lymphoblastic leukemia during induction therapy. Anticancer Res. 16:1996;3133.
14. Hannum Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 89:1997;1845.
15. Ellison R.R., Holland J.F., Weil M., Jacquillat C., Boiron M., Bernard J., Sawitsky A., Rosner F., Gussoff B., Silver R.T., Karanas A., Cuttner J., Spurr C.L., Hayes D.M., Blom J., Leone L.A., Haurani F., Kyle R., Hutchison J.L., Forcier R.J., Moon J.H. Arabinosyl cytosine. a useful agent in the treatment of acute leukemia in adults Blood. 32:1968;507.
16. Nara N., Suzuki T., Nagata K., Tohda S., Yamashita Y., Nakamura Y., Imai Y., Morio T., Minamihisamatsu M. Granulocyte colony-stimulating factor-dependent growth of an acute myeloblastic leukemia cell line. Jpn J Cancer Res. 81:1990;625.
17. Philpott N.J., Turner A.J.C., Scopes J., Westby M., Marsh J.C.W., Gordon-Smith E.C., Dalgleish A.G., Gibson F.M. The use of 7-amino actinomycin D in identifying apoptosis. simplicity of use and broad spectrum of application compared with other techniques Blood. 87:1996;2244.
18. Su I.-J., Cheng A.-L., Tsai T.-F., Lay J.-D. Retinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotype. Br J Haematol. 85:1993;826.
19. Moreira L.F., Naomoto Y., Hamada M., Kamikawa Y., Orita K. Assessment of apoptosis in esophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Anticancer Res. 15:1995;639.
20. Ishikura H., Sawada H., Okazaki T., Mochizuki T., Izumi Y., Yamagishi M., Uchino H. The effect of low dose Ara-C in acute non-lymphoblastic leukemias and atypical leukemia. Br J Haematol. 58:1984;9.